What are they and where are they used?
Isocyanates contain reactive chemical groups involved in the production of polyurethanes and other materials. Diisocyanates possess two of these groups and are particularly relevant in numerous industrial and professional applications. They can be found in products used for foams, paints, coatings, adhesives, and sealants.
The trade name alone does not indicate exposure. It is necessary to consult the composition, the safety data sheet, and the application conditions. Mixing components, spraying, cleaning equipment, or handling material that has not yet fully cured can lead to different situations. Furthermore, a reactive product should not be equated with a finished product without prior evaluation.
Occupational asthma is a particularly relevant effect when evaluating respiratory sensitizers such as diisocyanates. The onset of symptoms requires medical evaluation and a review of exposure conditions.
Health effects
Respiratory sensitization, including work-related asthma, and skin sensitization are effects that are relevant to prevention. Irritations may also occur. Manifestations do not always appear during operation, so the absence of immediate discomfort does not guarantee that the exposure is acceptable.
The assessment should consider both inhalation and skin contact. If compatible symptoms appear, consult a healthcare professional and investigate the exposure conditions. A tolerance test should not be improvised through repeated exposures. Individual assessment and appropriate measures require professional intervention and confidentiality.
Identify exposure scenarios
Volatility, temperature, application method, and aerosol generation all affect exposure. Spraying can produce very different conditions than manual application of the same product. Transfers, mixing, spills, and cleanup must also be considered, even if they are seen as auxiliary or short-duration operations.
The job description should include who has access to the area during and after the operation. Assistants, maintenance personnel, and other contractors may share exposure. It is helpful to reconstruct the entire sequence, from product receipt to waste management, and identify where an effective barrier to release exists.
Replacement, confinement and extraction
The substitution of hazardous agents should be studied when technically feasible, comparing the risks of the alternative with its actual application. When use continues, closed processes, reduced releases, and adequate local exhaust ventilation should be prioritized. Lower volatility alone does not eliminate the risk of aerosols or contact.
The measures must be effective during foreseeable tasks, including container changes and cleaning. It is advisable to establish usage and maintenance conditions, verify the effectiveness of the installations, and prevent access incompatible with the operation. Instructions should be specific to the product and process, rather than simply recommending ventilation in a generic way.
Skin and respiratory protection
Dermal exposure requires special attention. Protective gloves, clothing, and equipment connections must be selected based on information regarding their resistance and compatibility. The removal procedure and treatment of contaminated garments are just as important as having the appropriate equipment.
Respiratory protection must be appropriate for the substances, concentrations, and working conditions. Choosing equipment simply because it is used in another painting activity is not valid. The assessment must determine the need for and type of equipment, along with the conditions for proper fit, maintenance, use, and training. Equipment complements emissions control and does not excuse substandard installations.
Training and exposure assessment
The European restriction on diisocyanates establishes specific requirements for industrial and professional use, effective from August 24, 2023. When the individual and combined concentration is not less than 0.1% by weight, the required training must be ensured before use. Being below this threshold does not eliminate the general obligations for the prevention of chemical risks.
The training content must correspond to the use and operations performed. Furthermore, the assessment considers current limits and appropriate measurement methods, without automatically extrapolating results between substances. Biological control may be considered when there is a technical basis, with its references and limitations; not just any analysis should be presented as conclusive proof of safety.
Practical example
A company uses a two-component coating and only considers application time. The review reveals that the mixing takes place in a separate area and that cleaning the equipment involves frequent contact with product residue. Support staff were not included in the exposure description.
The plan redefines the entire process, studies alternatives, improves containment, and specifies equipment and training for each task. The verification includes application, mixing, and cleanup, as well as access conditions. This prevents improvements in the primary area from leaving significant exposure in secondary operations unaffected.
Monitoring and common errors
Periodic reviews should cover products, safety data sheets, formulation changes, the effectiveness of controls, and activities actually performed. The appearance of symptoms or incidents requires an assessment of the situation, without waiting for the regular review date. Staff observations help detect leaks, practices that are difficult to comply with, or discrepancies between shifts.
Common mistakes include equating the absence of odor with the absence of risk, ignoring skin exposure, focusing training solely on the person spraying, or assuming that any mask is sufficient. Effective prevention connects chemical identification, task assessment, and exposure control, while maintaining health surveillance as a complement to, not a substitute for, these measures.
